title: Treatment with allopurinol and itraconazole changes lytic activity in patients with chronic, low grade Trypanosoma cruzi infection.
authors.affiliation: Department of Biochemistry, Faculty of Medicine, University of Chile, Santiago, Chile.
authors.forename: G
authors.initials: G
authors.lastname: Sánchez
authors.forename: I
authors.initials: I
authors.lastname: Zulantay
authors.forename: J
authors.initials: J
authors.lastname: Venegas
authors.forename: A
authors.initials: A
authors.lastname: Solari
authors.forename: R
authors.initials: R
authors.lastname: Gálvez
authors.forename: P
authors.initials: P
authors.lastname: Peña
authors.forename: J
authors.initials: J
authors.lastname: Rodríguez
authors.forename: W
authors.initials: W
authors.lastname: Apt
mesh_terms: D000293:Adolescent; D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use*; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D014355:Chagas Disease / Q000188:drug therapy*; D002648:Child; D002908:Chronic Disease; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D008875:Middle Aged
chemical_list: D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D017964:Itraconazole; D000493:Allopurinol